Title : 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current - Drukarch_1987_Eur.J.Pharmacol_141_153 |
Author(s) : Drukarch B , Kits KS , Van der Meer EG , Lodder JC , Stoof JC |
Ref : European Journal of Pharmacology , 141 :153 , 1987 |
Abstract :
The in vitro release of acetylcholine in rat brain tissue was inhibited by 9-amino-1,2,3,4-tetrahydroacridine (THA). Atropine antagonized this effect of THA. As THA does not display an affinity for muscarinic receptors, we conclude that THA inhibits acetylcholinesterase activity. In electrophysiological studies with neurons of Lymnaea stagnalis, THA inhibited the slow outward K+ current and consequently increased the duration of the action potentials. It is discussed that both effects of THA possibly contribute to its reported effect in the treatment of patients with Alzheimer's disease. |
PubMedSearch : Drukarch_1987_Eur.J.Pharmacol_141_153 |
PubMedID: 2444444 |
Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC (1987)
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current
European Journal of Pharmacology
141 :153
Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC (1987)
European Journal of Pharmacology
141 :153